Nalaganje...
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia in the developed world and is associated with a fivefold increase in the risk of stroke, accounting for up to 15% of strokes in the general population. The European Society of Cardiology now recommends direct oral anticoagulants, such as...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3968084/ https://ncbi.nlm.nih.gov/pubmed/24711702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S30159 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|